T lymphocytes, commonly called T cells, are white blood cells that act as the core coordinators and enforcers of your immune system. They get their name from the thymus, a small organ above the heart where they mature. Unlike antibodies that float freely in your blood, T cells work by directly interacting with other cells, either killing infected ones, directing the broader immune response, or keeping that response in check so it doesn’t attack your own body.
Where T Cells Come From
T cells begin as stem cells in your bone marrow, the same place that produces all blood cells. Early in development, certain precursor cells leave the bone marrow and travel to the thymus, a gland located in the upper chest. This migration is what distinguishes T cells from B cells, the other major type of lymphocyte, which stay in the bone marrow to mature.
Inside the thymus, immature cells go through an intense selection process. The thymus has two main regions: an outer cortex where most development happens, and an inner medulla where nearly mature T cells gather before being released. In the outermost layer of the cortex, immature cells divide rapidly. As they move deeper into the cortex, they’re tested against proteins from your own body. Cells that react too strongly to your own tissues are eliminated, and cells that fail to recognize threats at all are also discarded. Only about 2% of developing T cells survive this screening and leave the thymus as functional, mature cells.
How T Cells Recognize Threats
Each T cell carries a unique protein on its surface called a T cell receptor, or TCR. This receptor works like a lock that fits only one specific key. But T cells can’t detect threats floating freely in the blood the way antibodies can. Instead, they rely on other cells to present fragments of proteins, called antigens, on their surface using special display molecules known as MHC (major histocompatibility complex).
When a cell in your body is infected by a virus, for example, it chops up viral proteins and displays the fragments on its surface via MHC molecules. A passing T cell with the right receptor recognizes that fragment, locks on, and activates. This system means T cells are constantly scanning other cells for signs of infection, damage, or cancerous changes. The binding between a T cell receptor and its target is relatively weak compared to antibody binding, but additional surface proteins on the T cell (called coreceptors) strengthen the connection and help trigger the cell’s response.
The Major Types of T Cells
T cells are not one uniform group. They differentiate into several specialized types, each with a distinct role. The two most well-known are helper T cells and cytotoxic T cells, distinguished by the surface markers CD4 and CD8.
Helper T Cells (CD4+)
Helper T cells carry the CD4 marker and function as the immune system’s organizers. They don’t kill infected cells directly. Instead, when they recognize a threat, they release chemical signals called cytokines that activate other immune cells: B cells start producing antibodies, cytotoxic T cells ramp up their killing activity, and macrophages become more aggressive at engulfing pathogens. Without helper T cells, the rest of the immune system operates in a disorganized, weakened state. In healthy adults and teens, CD4 counts typically range from 500 to 1,200 cells per cubic millimeter of blood.
Cytotoxic T Cells (CD8+)
Cytotoxic T cells carry the CD8 marker and are the immune system’s direct killers. When they find a cell displaying signs of infection or cancerous transformation, they deliver a lethal hit. They do this primarily by releasing two proteins: perforin, which punches holes in the target cell’s outer membrane, and granzymes, which enter through those holes and trigger a self-destruct program inside the cell. Granzyme B, the most studied of these, activates a chain reaction that causes the target cell to shrink, fragment its own DNA, and die in an orderly process called apoptosis. This controlled death prevents the contents of the infected cell from spilling out and causing inflammation.
Regulatory T Cells (Tregs)
Regulatory T cells are the immune system’s brakes. They express a protein called Foxp3 and work to prevent the immune system from overreacting or attacking the body’s own tissues. Tregs suppress immune responses through several mechanisms. They compete with other T cells for a growth signal called IL-2, essentially starving overactive immune cells. They also release anti-inflammatory signals like IL-10 and TGF-beta, which calm nearby immune cells. On top of that, they can interfere with the ability of antigen-presenting cells to activate new T cells in the first place, disrupting the interaction between those cells and conventional T cells before an immune response gets started.
When Tregs don’t function properly, the result is often autoimmune disease, where the immune system attacks healthy tissue.
How T Cells Build Immune Memory
One of the most important things T cells do is remember past infections. After a T cell fights off a pathogen, most of the activated cells die off. But a fraction survive as memory T cells, which can persist in the body for years or even decades. If the same pathogen appears again, these memory cells mount a secondary immune response that is faster and stronger than the first encounter. This is the principle behind vaccination.
Memory T cells come in several flavors. Central memory T cells circulate through the lymph nodes and spleen, ready to coordinate a broad response. Effector memory T cells patrol non-lymphoid tissues like the lungs, liver, and intestines, where they can respond immediately by releasing inflammatory signals and cytotoxic molecules like perforin and granzyme B. Tissue-resident memory T cells stay permanently stationed in specific locations, including the skin, gut lining, lungs, and even the brain, forming the very first line of defense. These resident cells respond faster than any other memory subset because they’re already at the likely site of reinfection. A newer category, stem memory T cells, can self-renew and give rise to all other memory subtypes, providing a long-lasting reservoir.
T Cells in Disease
Because T cells are so central to immune function, their disruption underlies a wide range of conditions.
HIV is the most well-known example of T cell depletion. The virus specifically infects CD4+ helper T cells, entering the cell, replicating inside it, and eventually destroying it. The newly produced virus particles then infect more CD4 cells, progressively hollowing out the immune system. When the CD4 count drops below 200 cells per cubic millimeter, down from the normal range of 500 to 1,200, the condition is classified as AIDS according to the Centers for Disease Control and Prevention. At that point, the body becomes vulnerable to infections and cancers that a healthy immune system would normally control.
On the opposite end, T cells that are too active or misdirected can cause autoimmune diseases. In type 1 diabetes, T cells attack the insulin-producing cells of the pancreas. In multiple sclerosis, they target the protective coating around nerve fibers in the brain and spinal cord. Primary biliary cirrhosis, an autoimmune liver disease, and sympathetic ophthalmia, a rare eye condition, are also driven primarily by T cell attacks against the body’s own tissues.
T Cells in Cancer Treatment
The ability of T cells to recognize and kill abnormal cells has made them a powerful tool in cancer therapy. The most prominent example is CAR T-cell therapy, which stands for chimeric antigen receptor T-cell therapy. In this approach, T cells are collected from a patient’s blood and sent to a lab, where they’re genetically engineered to produce a synthetic receptor on their surface. This receptor has an external portion made from antibody fragments that can latch onto a specific protein found on cancer cells, and an internal portion containing signaling components that activate the T cell upon binding.
Once infused back into the patient, these modified T cells seek out cancer cells carrying the target protein, bind to them, and kill them. The internal signaling domains also stimulate the CAR T cells to multiply further inside the body, amplifying the attack. This therapy has shown particular success in certain blood cancers and represents a broader shift toward using the body’s own immune cells as living drugs.